Oriola
0.938
EUR
-0.21 %
Corporate customer
OKDBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
7,651 following
-0.21%
+5.39%
+4.69%
+0.97%
-3.5%
-12.66%
-56.97%
-57.94%
-49%
Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.
Read moreMarket cap
170.23M EUR
Turnover
53.89K EUR
P/E (adj.) (24e)
25.05
EV/EBIT (adj.) (24e)
4.13
P/B (24e)
1.08
EV/S (24e)
0.05
Dividend yield-% (24e)
8.53 %
Financial calendar
4.3
2025
Annual report '24
2.4
2025
General meeting '25
29.4
2025
Interim report Q1'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
Oriola Oyj: Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek
Oriola Oyj: Oriola renews operating model and management team to accelerate strategy execution
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools